Global Gene Therapy Market Growth (Status and Outlook) 2023-2029

Global Gene Therapy Market Growth (Status and Outlook) 2023-2029

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

LPI (LP Information)' newest research report, the “Gene Therapy Industry Forecast” looks at past sales and reviews total world Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Therapy sales for 2023 through 2029. With Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy industry.

This Insight Report provides a comprehensive analysis of the global Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy.

The global Gene Therapy market size is projected to grow from US$ 6923.7 million in 2022 to US$ 40340 million in 2029; it is expected to grow at a CAGR of 28.6% from 2023 to 2029.

Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.

North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.

In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Viral Gene Therapy

Non-Viral Gene Therapy

Segmentation by application

Neurological Diseases

Cancer

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen

Spark Therapeutics

Akcea Therapeutics

bluebird bio

Sunway Biotech

SIBIONO

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Please note: The report will take approximately 2 business days to prepare and deliver.